General
- Type: Vasopressors
- Technically an inotrope as beta 2 stimulation causes vasodilation
- Should use in combination with a vasopressor (eg norepinephrine) to avoid hypotension
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Dosing
- 2-20mcg/kg/min
- May use in peripheral IV
Rate of Titration
Pediatric Dosing
Special Populations
- Pregnancy Rating: B
- Lactation:
- Unknown if Dobutamine passes into breast milk
- Renal Dosing
- Hepatic Dosing
Contraindications
Adverse Reactions
- Tachyarrhythmias
- Myocardial ischemia
- Hypotension as β2 effect may result in vasodilation
Serious
Common
Pharmacology[1]
- Half-life:
- Metabolism:
- In tissues and hepatically
- Excretion:
- Mechanism of Action:β1 stimulation with variable BP effects
Primary Receptor
Relative Effects
- ↑↑↑SV
- ↑↑HR → increases oxygen demand of heart → can worsen ischemia
- ↓SVR (transient, from β2 agonism)
Notes
Indications
- Cardiogenic shock
- initial agent in low-output heart failure without requiring BP support
- Tricyclic overdose
- septic shock with low cardiac output to improve blood flow
See Also
http://www.atsjournals.org/doi/abs/10.1164/rccm.201006-0972CI?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed#readcube-epdf
References
- ↑ Dobutamine: Drug information. UpToDate. www.uptodate.com. Accessed April 2, 2019.